Objective: There are limited studies of cytology diagnosis of haematopoietic and lymphoid tumours in serosal effusion except for occasional case reports. We would like to demonstrate an algorithmic approach for accurate diagnosis, especially in patients without previous history.
| INTRODUCTION
Cytological diagnosis of haematolymphoid neoplasm in serosal effusions remains challenging because of its rarity, great morphological variations and complexity of subtyping.
According to previous reports, serosal effusions were a common complication of lymphoma. 1 In this study, we reviewed the cytopathology, immunophenotype and cytogenetic alterations of 36 lymphoid haematopoietic tumours diagnosed in effusions and discuss the importance of an algorithmic approach in diagnosing the disease, especially for primary lesions first presenting in effusion, in which accurate diagnosis may lead to prompt and effective clinical management and prolong patients' survival.
| MATERIALS AND METHODS
In this retrospective study, we collected 36 haematopoietic and lymphoid tumours diagnosed in effusion samples from two general hospitals from 2011 to the first quarter of 2016. They included nine ascites and 27 pleural effusions, with an average age of 63.3 and a male to female ratio of 23:13. Twenty-eight of them had IHC confirmation, and cytogenetic studies were performed in 22 of them. The other eight cases were diagnosed based on haematoxylin and eosin morphology exclusively, with previous pathology confirmation.
| Cytology preparation of effusion
Samples (5 mL) of each effusion were routinely processed using Cytospin â (Sakura, Finetek, Japan) to prepare a conventional smear followed by immediate fixation in 95% ethanol. Another 50 mL was centrifuged at 400 g to prepare a ThinPrep â (Hologic, Boston, MA, were carried out on 3-lm thick sections from the cell block.
| Algorithmic approach
An algorithmic approach combining morphology, immunophenotyping and genomics was applied on smears and cell blocks in three steps as follows ( Figure 1 ). Besides DLBCL, there were three cases of small to medium sized lymphoma of B-cell origin which all had previous history. A confirmation approach was applied with characteristic markers. These included two cases of MCL, which were diagnosed by strong expression of Cyclin D1 and CD20, and were further confirmed by The second most common neoplasm was PCM in our collection, accounting for 12 cases, of which seven had IHC and five were diagnosed based on morphology alone with previous bone marrow biopsy. Genetic abnormality was detected in four out of six cases by FISH as shown in Table 2 . They were all pleural effusions, with male:female ratio of 3:1 and average age of 59. of prominent nucleoli as shown in one case, which also had 1q21 amplification ( Figure 3 ). These two cases were diagnosed as plasmablastic or anaplastic PCM based on absence of previous history of PCM and negativity of EBER ISH, and one was also negative for HHV8. 8 One case of an 88-year-old man (Table 2) 
| Morphological assessment

| Molecular studies
| Tumors of T-cell origin in the effusion
Following the algorithm, there were five lymphomas of T-cell origin.
Two cases were T-ALL/LBL diagnosed in pleural effusion as the first clinical presentation. They consisted of small to medium sized monotonous lymphoid cells with round to convoluted nuclei of dispersed chromatin as previously reported in our paper. 5 They were T-cell predominant, demonstrating strong TDT and CD99 expression (Table 3) . Active proliferation was indicated by prominent apoptotic bodies and mitosis. T-cell evolution demonstrated by immunophenotype was also studied. No genetic abnormality was detected by FISH.
The other three cases were classified into mature T-cell lymphoma (Table 3) Figure 4 , Epstein-Barr encoding region in situ hybridisation and human herpesvirus 8 were both negative in this case (not shown). Amplification of 1q21 (red dots) was detected in 32% of tumour cells, while no deletion was observed for RB (green dots), indicating aggressiveness and poor prognosis of the disease (E, 91000).
NOS after other specific entities were excluded. However, the origin remains unresolved because of widespread infiltration of the tumour and inoperable abdominal mass.
| DISCUSSION
Tumours of haematopoietic origin in effusion are characterised by diffuse cellularity, discohesive pattern and monotonous morphol- . Mitosis can be frequently observed (arrowhead), but there was no obvious necrosis. There was very sparse expression of CD3 and hardly any expression of CD20 (not shown). The cells had a high Ki-67 proliferation index (B, 9200). As they were terminally differentiated, with a B-cell origin, they were strongly reactive for CD138 (C, 9200). Monotypic light chain expression was observed for Kappa (D, 9200), not for Lambda (not shown). Epstein-Barr encoding region in situ hybridisation was highly positive (E, 9200) and human herpesvirus 8 was negative (not shown). However, EBER ISH is often positive in PBL, while plasmablastic PCM is always negative, as shown in our collection. 8, 9 A DE DLBCL was also observed in our collection, which had MYC immunopositivity in 40% of tumour cells, BCL2 in over 60% and a high Ki-67 index (over 90% of cells). DE DLBCL is reported to be associated with a non-germinal center phenotype, which was also true in this case.
Although still controversial, it is associated with aggressiveness and poor prognosis. 7, 12 The patient was still alive after 4 months of treatment.
Through a combination of morphology and immunophenotyping, we diagnosed 14 cases of haematolymphoid neoplasms in patients with effusion as the initial clinical manifestation. It included 7 DLBCL, two plasmablastic or anaplastic PCM, one PBL, one PTCL NOS, one extranodal NK/T-cell lymphoma, nasal type and two T-ALL/LBL. One DLBCL and the PTCL NOS were later confirmed by biopsy. The two T-ALL/LBL cases were fully described in our previous paper. 5 This is of great importance in clinical management, as most of them were suspected to have TB or lung carcinoma on admission.
Besides morphology recognition and IHC phenotyping as discussed above, we consider cytogenetic study by FISH to be a good supplement to the accurate diagnosis and a reference to prognosis.
CCND1/IGH fusion is present in almost all MCL and considered the primary genetic event as shown in the common variant MCL in our collection ( Figure 2E,F) . 13, 14 However, tetraploidy was discov- reported to have a significantly higher tendency to harbour tetraploidy as compared to the common variant MCL. 14 This might explain the diffuse expression of cyclin D1 subject to confirmation from other studies. ALK break apart is detected in over 90% of ALCL, ALK+ cases and it was also detected in our case. 15 MYD 88 L265P mutation is also diagnostic for lymphoplasmacytic lymphoma as over 90% of tumours have the mutation by PCR. 16 A suspected effusion with previous history of lymphoplasmacytic lymphoma was excluded in our study because of ambiguous immunophenotype and absence of the MYD 88 L265P mutation. Cytogenetic abnormalities are common in haematopoietic tumours, although they may lack primary genetic characteristics. In DLBCL, BCL6 break apart is the most common translocation, accounting for 30% of cases, 17 followed by BCL2 translocation, which occurs in 20%-30% of cases, 18 The most frequent chromosome translocation in PCM is IGH translocation on 14q32, accounting for 55%-70% of tumours. 2 We detected this translocation in 3/6 PCM and the rest had either TP53
or RB deletion, which are associated with poorer prognosis as compared with IGH translocation. About 50% of CLL/SLL shows del 13q14.3 as detected in our case, followed less commonly by deletion of 11q22-23, or TP53. 20 A 13q14.3 deletion also provides strong evidence for diagnosis of CLL/SLL, which often lacks morphological characteristics, as discussed before. There is no prevalent genetic abnormality in T-ALL/LBL despite a range of genetic abnormalities reported, including 6q or P16 deletion. 2 Neither 6q nor P16 deletion was detected in our cases of T-ALL/LBL.
| CONCLUSION
We have shown clearly that an algorithm ( Figure 1 ) based on morphology and IHC with molecular pathology makes appropriate and accurate subclassification of malignant lymphoma possible in effusion samples, which is sometimes difficult to do otherwise. Morphological observation based on cell size and characteristics forms the fundamental step, which may give the correct diagnosis in combination with previous history. Immunophenotyping on cell blocks is followed directed by morphology observation. A basic panel of CD3, CD20
and Ki-67 may reveal B-or T-cell originality of tumours and representative markers in specific panels lead to specific diagnosis. EBER ISH plays an important role for differential diagnosis as showed in our collection. Furthermore, molecular genotyping is a good supplement to diagnosis and prediction of prognosis. It may play a more important role in tumour classification and treatment in the future.
We have now realised the importance of application of FCM in routine cytopathological diagnosis, which is now being set up in our laboratory. FCM has great advantage over routine morphology in diagnosing B-cell lymphoma with light chain restriction, especially for low grade lymphoma, which has mild atypia to be recognised by 
